That we allow (or proposed allowing, I can't remember if it went forward) US producers to send fish and poultry etc. to China for processing and return it to us and it can be labeled as Product of the USA without any mention of the trip to China is pretty freaky.
That we allow (or proposed allowing, I can't remember if it went forward) US producers to send fish and poultry etc. to China for processing and return it to us and it can be labeled as Product of the USA without any mention of the trip to China is pretty freaky.
This conspiracy is not required. The wet markets and "wild flavor" restaurants are enough of a global hazard. That we allow (or proposed allowing, I can't remember if it went forward) US producers to send fish and poultry etc. to China for processing and return it to us and it can be labeled as Product of the USA without any mention of the trip to China is pretty freaky. And I don't doubt there was/is skullduggery too. But it's not required for us to be upset. We need to protect our food supply but hey let's MAGA the USDA and WHO and CDC and get pissed after the wheels fall off. Makes sense.
And there we go. Winner winner partial chicken dinner ? Lab assistant brought the bug home & infected her boyfriend is the version I'm reading.
Sources believe coronavirus originated in Wuhan lab as part of China's efforts to compete with US
... but it's FauxNewz!!!! I can already hear the whining from my house.
And if you really think the media who incessantly report info from claimed anonymous sources are also straight dealing and not lying to you, or plain making shit up ... you might be a kook too.
I thought it was pretty much down to a lab worker was pinching dead infected testing bats from the lab and selling them in the local "wet" market,"thinking" that there was no risk to humans by eating them. The bats are a delicacy there and fetch some bucks.
It was the first thing I heard about the source, the "wet" market, way back very early on. Cross contamination with other feral animals in unsanitary conditions. Then you never heard about it again. Evidently just acknowledging that this kind of market still exists was an embarrassment to the Chinese government. More often than not in stories too weird to be true, the first reports are trueist, then the cover up begins. Feel free to call me crazy, but it's my story and I'm sticking to it ...
Reading that report, it sounds plausible that the researcher, or an assistant, were bitten or otherwise infected in the level 2 lab & eventually became contagious. From that point, at least one visited the wet market and infected others there. That would be the working hypothesis presented. So - not deliberate, not a government action, but not really an unavoidable accident either. A level 4 lab has the highest of precautions and standards. A level 2 lab does not. This work should have been conducted in a level 4 lab. So - sloppy & incompetent. The other question left unanswered is why has China been gathering data & researching coronaviruses in the first place?
And there we go. Winner winner partial chicken dinner ? Lab assistant brought the bug home & infected her boyfriend is the version I'm reading.
Sources believe coronavirus originated in Wuhan lab as part of China's efforts to compete with US
"The sources believe the initial transmission of the virus was bat-to-human, and that "patient zero" worked at the laboratory, then went into the population in Wuhan."
"The âincreasing confidenceâ comes from classified and open-source documents and evidence, the sources said."
"Documents detail early efforts by doctors at the lab and early efforts at containment. The Wuhan wet market initially identified as a possible point of origin never sold bats, and the sources tell Fox News that blaming the wet market was an effort by China to deflect blame from the laboratory, along with the country's propaganda efforts targeting the U.S. and Italy."
... but it's FauxNewz!!!! I can already hear the whining from my house.
Today is by far the worst we've had. Almost double yesterday's optimistic number. Which is a reminder to step back from the dailies and try to watch the trends. Still flattening, generally, but it isn't over and we're going to have more bad days.
A combination of the need for mental health ... fighting a hypnotic can't-stop-looking aspect of human nature. April-May will be some hard months. Mental health will be especially fragile.
One of the scariest things about the new coronavirus is that there arenât any validated treatments. Plenty of ideas are in the works: a decades-long anti-malaria pill, blood components from people whoâve recovered, broad spectrum anti-viral drugs originally designed for Ebola. None of these are new.
Given their familiarity, repurposing existing drugs may be a highway to quick Covid-19 treatments. Many are hurtling through clinical trials. Yet also rushing ahead with lightning speed is another type of initiative, something extremely classic but now tinted with the urgency of a pandemic: de novo drug discovery, or developing drugs from near scratch.
In a way, finding drugs that specifically target SARS-CoV-2, the virus that causes Covid-19, is more intimate than repurposing drugs. Rather than scouring through candidates that might work for many targets, these efforts focus on the virus itself, trying to tease apart single âweak spotsâ that allow man-made chemicals to disrupt its replication. Itâs the type of process thatâs entirely traditional to the pharmaceutical industryâbut now, itâs accelerated to a mind-bending timeline previously completely inconceivable.
You may have heard the rule of thumb that a new drug against a new target takes at least 10 years to develop. For Covid-19, try months. Thanks to previous coronaviruses SARS and MERS, scientists have a general idea of how they work: how they infect cells, how they replicate, what types of tissues they prefer. Last week, the pharmaceutical giant Pfizer announced its intent to start human tests on a potential new drug for SARS-Cov-2 this fall, in case the virus or its cousin returns for the next go-around.
Pfizerâs hardly the only player. A slight silver lining to the loss and devastation Covid-19 has caused is a global unification of researchers to tackle the disease. Now more than ever, scientists around the globe are halting their own research and battling a common enemy. The result is a dramatically accelerated drug discovery timeline: from target discovery to candidate testing, while pulling out all the stops modern science has to offer usâlab-grown mini-organs, for example.
Hereâs a deep dive into one Covid-19 drug candidate, APN01, in the pipeline. APN01 is already in Phase II clinical trials in the EU and China, meaning that itâs been shown safe and is now being tested for efficacy in limited numbers. While APN01 may not necessarily be the hero that saves the day, it does provide a look at whatâs possible in drug discovery when the world unitesâan aspiration that will hopefully carry to other fields, such as Alzheimerâs or heart disease, long after the pandemic dies. more
Today is by far the worst we've had. Almost double yesterday's optimistic number. Which is a reminder to step back from the dailies and try to watch the trends. Still flattening, generally, but it isn't over and we're going to have more bad days.
Agreed. Any upcoming days in the graph will still have large numbers of (undercounted) deaths that require(d) a lot of work/investment/response. It's only over when it drops to around zero.
Today is by far the worst we've had. Almost double yesterday's optimistic number. Which is a reminder to step back from the dailies and try to watch the trends. Still flattening, generally, but it isn't over and we're going to have more bad days.
One of the last counties in the US to record a Covid-19 case is the next county over from us... the guy was diagnosed in this county and it sounds like he might have deliberately acted to spread his germs around.
Most of the new case in China are reportedly people entering the country - especially from Russia which makes me suspicious that the Russia infections are underestimated more than the underestimations in other countries.
